Thromboelastography‐Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial

Manoj Kumar, Juned Ahmad, Rakhi Maiwall, Ashok Choudhury, Meenu Bajpai, Lalita G. Mitra, Vandana Saluja, Prashant Mohan Agarwal, Chhagan Bihari, Saggere Muralikrishna Shasthry, Ankur Jindal, Ankit Bhardwaj, Guresh Kumar, Shiv K.

A Noncoding Regulatory RNAs Network Driven by Circ‐CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma

Yanping Wei, Xin Chen, Chi Liang, Yan Ling, Xinwei Yang, Xiaofei Ye, Hailing Zhang, Pinghua Yang, Xiuliang Cui, Yibing Ren, Xianglei Xin, Hengyu Li, Ruoyu Wang, Wenjing Wang, Feng Jiang, Suiyi Liu, Jing Ding, Baohua Zhang, Liang Li, Hongyang Wang – 30 May 2019 – Hepatocellular carcinoma (HCC) is one of the fastest‐rising causes of cancer‐related death worldwide, but its deficiency of specific biomarkers and therapeutic targets in the early stages lead to severe inadequacy in the early diagnosis and treatment of HCC.

Subscribe to